Pulse Biosciences Inc.

NASDAQ: PLSE · Real-Time Price · USD
16.12
-1.19 (-6.87%)
At close: Aug 15, 2025, 12:34 PM

Pulse Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 1.66M n/a n/a n/a 1.74M n/a n/a n/a -9K n/a 265K 444K 844K 574K n/a n/a
Cost of Revenue
267K 283K 832K 267K 266K 299K 304K 266K 302K 302K 1.29M 8.4M 1.34M 909K 1.24M 727K 266K 280K
Gross Profit
-267K -283K 832K -267K -266K -299K 1.44M -266K -302K -302K -1.3M -8.4M -1.08M -465K -397K -153K -266K -280K
Operating Income
-20.27M -18.04M -20.26M -13.65M -11.73M -10.62M -12.53M -11.25M -10.23M -9.56M -8.74M -18.02M -14.01M -17.27M -15.41M -14.27M -14.81M -18.52M
Interest Income
1.11M 1.25M 876K 975K 343K 478K 600K 686K 317K 561K 267K 14K 18K n/a n/a n/a n/a n/a
Pretax Income
-19.17M -16.8M -19.39M -12.68M -11.38M -10.14M -11.93M -10.57M -9.91M -9.8M -9.2M -18.04M -14M -17.27M -15.42M -14.28M -15.32M -18.64M
Net Income
-19.17M -16.8M -19.39M -12.68M -11.38M -10.14M -11.93M -10.57M -9.91M -10.28M -9.17M -18.05M -13.98M -17.27M -15.42M -14.28M -15.32M -18.64M
Selling & General & Admin
7.92M 7.73M 9.6M 5.95M 4.23M 3.58M 4.43M 3.78M 3.53M 3.73M 3.35M 5.11M 7.48M 10.04M 9.36M 7.66M 7.35M 9.46M
Research & Development
12.09M 10.31M 10.66M 7.7M 7.23M 6.74M 7.8M 7.47M 6.7M 5.83M 4.09M 4.52M 5.46M 6.77M 5.66M 6.46M 7.46M 9.06M
Other Expenses
n/a n/a n/a n/a n/a n/a 304K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
20.01M 18.04M 20.26M 13.65M 11.46M 10.32M 12.53M 11.25M 10.23M 9.56M 7.45M 9.63M 12.94M 16.81M 15.01M 14.12M 14.81M 18.52M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 800K 452K 14K n/a n/a 6K 9K 517K 114K
Selling & Marketing Expenses
n/a n/a n/a n/a -266K -299K -304K n/a n/a n/a 768K 2.02M 3.69M 5.54M 4.05M 3.4M 3.15M 4.15M
Cost & Expenses
20.27M 18.04M 20.26M 13.65M 11.73M 10.62M 12.53M 11.25M 10.23M 9.56M 8.74M 18.02M 14.28M 17.72M 16.25M 14.85M 14.81M 18.52M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a 478K -28K 14K -18K n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
67.28M 67.13M 58.4M 61.07M 57.18M 55.17M 55.06M 54.92M 44.51M 37.39M 37.23M 37.16M 31.49M 29.75M 29.64M 29.61M 26.48M 26.07M
Shares Outstanding (Diluted)
67.28M 67.13M 58.4M 61.07M 57.18M 55.17M 55.06M 54.92M 44.51M 37.39M 37.23M 37.16M 31.49M 29.75M 29.64M 29.61M 26.48M 26.07M
EPS (Basic)
-0.28 -0.25 -0.33 -0.21 -0.2 -0.18 -0.22 -0.19 -0.22 -0.27 -0.25 -0.49 -0.44 -0.58 -0.52 -0.48 -0.58 -0.71
EPS (Diluted)
-0.28 -0.25 -0.33 -0.21 -0.2 -0.18 -0.22 -0.19 -0.22 -0.27 -0.25 -0.49 -0.44 -0.58 -0.52 -0.48 -0.58 -0.71
EBITDA
-18.9M -18.04M -19.97M -13.36M -11.43M -10.32M -12.23M -10.95M -9.93M -9.26M -8.41M -17.69M -13.66M -16.95M -15.11M -13.99M -14.52M -18.25M
EBIT
-19.17M -16.8M -20.26M -13.65M -11.73M -10.62M -12.53M -11.25M -10.23M -9.56M -8.74M -18.02M -14.01M -17.27M -15.41M -14.27M -14.81M -18.52M
Depreciation & Amortization
267K 283K 287K 294K 266K 299K 304K 266K 302K 302K 336K 339K 367K 326K 297K 267K 266K 280K